PMID: 11480902Aug 2, 2001Paper

Acute respiratory failure caused by leukaemic infiltration of the lung of a dog

The Journal of Small Animal Practice
T MoriToru Fujinaga

Abstract

A seven-year-old crossbred male dog with a suspected leukaemic condition was referred for investigation and treatment. A bone marrow aspirate revealed an acute myeloid leukaemia. Combination chemotherapy was administered and the dog initially improved, but 18 days after the initiation of therapy its body condition deteriorated and the animal developed acute respiratory distress. On postmortem examination, extensive leukaemic pulmonary infiltrates were evident.

References

Mar 1, 1979·Chest·G P Bodey
Feb 1, 1974·American Journal of Clinical Pathology·J S Ross, L Ellman
Jun 1, 1966·Cancer·G P BodeyE J Freireich
Nov 1, 1983·Investigative Radiology·C W MaileC E Putman
Aug 1, 1993·American Journal of Hematology·S MeyerM Dicato
May 12, 1955·The New England Journal of Medicine·D J NATHAN, M SANDERS

Citations

Sep 6, 2005·The Journal of Veterinary Medical Science·Satoshi TakagiToru Fujinaga
Apr 11, 2007·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Takashi Masudo, Tetsuo Okada

Related Concepts

Bone Marrow Cells
Sudden Death
Differential Diagnosis
Dog Diseases
Canis familiaris
Leukemia, Monocytic, Chronic
Lung
Respiratory Failure
Leukemic Infiltration

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.